ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Offers Grant Supplements

March 5, 1999

NCI Awards $15M For Studies Of Glycobiology.

September 28, 2007

NCI Launches ALCHEMIST

September 5, 2014

Committee To Set Research Agenda On Breast Cancer. Justice Department Appeals Injunction On Stem Cell Research

September 3, 2010

O’Leary Leads RPCI’s OR;

February 8, 2002

In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh

January 1, 1988